Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 701

1.

Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial.

Rebholz CM, Zheng Z, Grams ME, Appel LJ, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Am J Clin Nutr. 2019 Feb 8. doi: 10.1093/ajcn/nqy202. [Epub ahead of print]

PMID:
30753252
2.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J, Vasan RS, Anderson AH, Feldman HI, Kimmel PL, Waikar SS, Köttgen A, Evans AM, Levey AS, Inker LA, Sarnak MJ, Grams ME; Chronic Kidney Disease Biomarkers Consortium Investigators.

Clin J Am Soc Nephrol. 2019 Feb 7. pii: CJN.10010818. doi: 10.2215/CJN.10010818. [Epub ahead of print]

PMID:
30733224
3.

Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.

Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC.

Atherosclerosis. 2018 Dec 30;282:52-56. doi: 10.1016/j.atherosclerosis.2018.12.022. [Epub ahead of print]

PMID:
30685442
4.

Statistical methods for building better biomarkers of chronic kidney disease.

Pencina MJ, Parikh CR, Kimmel PL, Cook NR, Coresh J, Feldman HI, Foulkes A, Gimotty PA, Hsu CY, Lemley K, Song P, Wilkins K, Gossett DR, Xie Y, Star RA.

Stat Med. 2019 Jan 21. doi: 10.1002/sim.8091. [Epub ahead of print]

PMID:
30663113
5.

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS.

Freed TA, Coresh J, Inker LA, Toal DR, Perichon R, Chen J, Goodman KD, Zhang Q, Conner JK, Hauser DM, Vroom KET, Oyaski ML, Wulff JE, Eiríksdóttir G, Gudnason V, Torres VE, Ford LA, Levey AS.

Clin Chem. 2019 Jan 15. pii: clinchem.2018.288092. doi: 10.1373/clinchem.2018.288092. [Epub ahead of print]

PMID:
30647123
6.

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.

Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM, Hou FF, Lewis JB, Locatelli F, Praga M, Schena FP, Levey AS, Inker LA; Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139. doi: 10.1016/S2213-8587(18)30314-0. Epub 2019 Jan 8.

PMID:
30635226
7.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
8.

Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis.

Zonozi R, Wu A, Shin JI, Secora A, Coresh J, Inker LA, Chang AR, Grams ME.

Mayo Clin Proc. 2019 Jan;94(1):17-26. doi: 10.1016/j.mayocp.2018.08.034.

PMID:
30611444
9.

Variability of Two Metabolomic Platforms in CKD.

Rhee EP, Waikar SS, Rebholz CM, Zheng Z, Perichon R, Clish CB, Evans AM, Avila J, Denburg MR, Anderson AH, Vasan RS, Feldman HI, Kimmel PL, Coresh J; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):40-48. doi: 10.2215/CJN.07070618. Epub 2018 Dec 20.

PMID:
30573658
10.

Adherence to the Dietary Approaches to Stop Hypertension Dietary Pattern and Risk of Abdominal Aortic Aneurysm: Results From the ARIC Study.

Haring B, Selvin E, He X, Coresh J, Steffen LM, Folsom AR, Tang W, Rebholz CM.

J Am Heart Assoc. 2018 Nov 6;7(21):e009340. doi: 10.1161/JAHA.118.009340.

11.

Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial.

Deal JA, Goman AM, Albert MS, Arnold ML, Burgard S, Chisolm T, Couper D, Glynn NW, Gmelin T, Hayden KM, Mosley T, Pankow JS, Reed N, Sanchez VA, Richey Sharrett A, Thomas SD, Coresh J, Lin FR.

Alzheimers Dement (N Y). 2018 Oct 5;4:499-507. doi: 10.1016/j.trci.2018.08.007. eCollection 2018.

12.

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.

Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; CKD Prognosis Consortium.

Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19.

PMID:
30348535
13.

Life's Simple 7 and Peripheral Artery Disease Risk: The Atherosclerosis Risk in Communities Study.

Garg PK, O'Neal WT, Mok Y, Heiss G, Coresh J, Matsushita K.

Am J Prev Med. 2018 Nov;55(5):642-649. doi: 10.1016/j.amepre.2018.06.021.

PMID:
30342629
14.

Coffee consumption and liver-related hospitalizations and deaths in the ARIC study.

Hu EA, Lazo M, Selvin E, Hamilton JP, Grams ME, Steffen LM, Coresh J, Rebholz CM.

Eur J Clin Nutr. 2018 Oct 19. doi: 10.1038/s41430-018-0346-0. [Epub ahead of print]

PMID:
30341433
15.

Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease.

Han Z, Xiao Z, Kalantar-Zadeh K, Moradi H, Shafi T, Waikar SS, Quarles LD, Yu Z, Tin A, Coresh J, Kovesdy CP.

Diagnostics (Basel). 2018 Oct 8;8(4). pii: E71. doi: 10.3390/diagnostics8040071.

16.

Chronic kidney disease measures and the risk of abdominal aortic aneurysm.

Matsushita K, Kwak L, Ballew SH, Grams ME, Selvin E, Folsom AR, Coresh J, Tang W.

Atherosclerosis. 2018 Dec;279:107-113. doi: 10.1016/j.atherosclerosis.2018.08.043. Epub 2018 Sep 1.

PMID:
30290962
17.

Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk.

Seidelmann SB, Feofanova E, Yu B, Franceschini N, Claggett B, Kuokkanen M, Puolijoki H, Ebeling T, Perola M, Salomaa V, Shah A, Coresh J, Selvin E, MacRae CA, Cheng S, Boerwinkle E, Solomon SD.

J Am Coll Cardiol. 2018 Oct 9;72(15):1763-1773. doi: 10.1016/j.jacc.2018.07.061.

18.

Estimated GFR and Hospital-Acquired Infections Following Major Surgery.

Ishigami J, Trevisan M, Xu H, Coresh J, Matsushita K, Carrero JJ.

Am J Kidney Dis. 2019 Jan;73(1):11-20. doi: 10.1053/j.ajkd.2018.06.029. Epub 2018 Sep 7.

PMID:
30201545
19.

A comprehensive evaluation of the genetic architecture of sudden cardiac arrest.

Ashar FN, Mitchell RN, Albert CM, Newton-Cheh C, Brody JA, Müller-Nurasyid M, Moes A, Meitinger T, Mak A, Huikuri H, Junttila MJ, Goyette P, Pulit SL, Pazoki R, Tanck MW, Blom MT, Zhao X, Havulinna AS, Jabbari R, Glinge C, Tragante V, Escher SA, Chakravarti A, Ehret G, Coresh J, Li M, Prineas RJ, Franco OH, Kwok PY, Lumley T, Dumas F, McKnight B, Rotter JI, Lemaitre RN, Heckbert SR, O'Donnell CJ, Hwang SJ, Tardif JC, VanDenburgh M, Uitterlinden AG, Hofman A, Stricker BHC, de Bakker PIW, Franks PW, Jansson JH, Asselbergs FW, Halushka MK, Maleszewski JJ, Tfelt-Hansen J, Engstrøm T, Salomaa V, Virmani R, Kolodgie F, Wilde AAM, Tan HL, Bezzina CR, Eijgelsheim M, Rioux JD, Jouven X, Kääb S, Psaty BM, Siscovick DS, Arking DE, Sotoodehnia N.

Eur Heart J. 2018 Nov 21;39(44):3961-3969. doi: 10.1093/eurheartj/ehy474.

PMID:
30169657
20.

Effects of Body Size and Composition on Sex Differences in Measured GFR in a US Community-Based Older Cohort (MESA-Kidney).

Abraham AG, Shafi T, Tighiouart H, Moseley KF, Post WS, Inker LA, Coresh J, Shlipak MG, Levey AS.

Am J Kidney Dis. 2018 Nov;72(5):767-770. doi: 10.1053/j.ajkd.2018.05.012. Epub 2018 Jul 21. No abstract available.

PMID:
30041875
21.

Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME.

Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.

PMID:
30039344
22.

Biological Variability of Estimated GFR and Albuminuria in CKD.

Waikar SS, Rebholz CM, Zheng Z, Hurwitz S, Hsu CY, Feldman HI, Xie D, Liu KD, Mifflin TE, Eckfeldt JH, Kimmel PL, Vasan RS, Bonventre JV, Inker LA, Coresh J; Chronic Kidney Disease Biomarkers Consortium Investigators.

Am J Kidney Dis. 2018 Oct;72(4):538-546. doi: 10.1053/j.ajkd.2018.04.023. Epub 2018 Jul 18.

PMID:
30031564
23.

Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.

Kim ED, Tanaka H, Ballew SH, Sang Y, Heiss G, Coresh J, Matsushita K.

Am J Kidney Dis. 2018 Nov;72(5):682-690. doi: 10.1053/j.ajkd.2018.04.018. Epub 2018 Jul 12.

PMID:
30007506
24.

Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.

Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.

PMID:
30002224
25.

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.

Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden WE, Bonaca MP, Carrero JJ, Coresh J, D'Agostino RB Sr, Elley CR, Fowkes FGR, Jee SH, Kovesdy CP, Mahaffey KW, Nadkarni G, Peterson ED, Sang Y, Matsushita K.

J Am Heart Assoc. 2018 Jul 7;7(14). pii: e008426. doi: 10.1161/JAHA.117.008426.

26.

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC.

J Am Coll Cardiol. 2018 Jul 10;72(2):156-169. doi: 10.1016/j.jacc.2018.04.050.

PMID:
29976289
27.

Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study.

Lee AK, Rawlings AM, Lee CJ, Gross AL, Huang ES, Sharrett AR, Coresh J, Selvin E.

Diabetologia. 2018 Sep;61(9):1956-1965. doi: 10.1007/s00125-018-4668-1. Epub 2018 Jun 30.

PMID:
29961106
28.

Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination.

Bae S, Massie AB, Thomas AG, Bahn G, Luo X, Jackson KR, Ottmann SE, Brennan DC, Desai NM, Coresh J, Segev DL, Garonzik Wang JM.

Am J Transplant. 2019 Feb;19(2):425-433. doi: 10.1111/ajt.14978. Epub 2018 Jul 14.

PMID:
29935051
29.

Serum untargeted metabolomic profile of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern.

Rebholz CM, Lichtenstein AH, Zheng Z, Appel LJ, Coresh J.

Am J Clin Nutr. 2018 Aug 1;108(2):243-255. doi: 10.1093/ajcn/nqy099.

PMID:
29917038
30.

Identifying Trends in Undiagnosed Diabetes in U.S. Adults.

Selvin E, Wang D, Lee AK, Coresh J, Bergenstal RM.

Ann Intern Med. 2018 Jun 19;168(12):900-901. doi: 10.7326/L18-0098. No abstract available.

PMID:
29913500
31.

Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes: A Prospective Cohort Study.

Selvin E, Wang D, Matsushita K, Grams ME, Coresh J.

Ann Intern Med. 2018 Aug 7;169(3):156-164. doi: 10.7326/M18-0091. Epub 2018 Jun 19.

PMID:
29913486
32.

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Chen TK, Hayek SS, Tracy M, Lipkowitz MS, Appel LJ, Levey AS, Inker LA, Reiser J, Grams ME.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1013-1021. doi: 10.2215/CJN.13631217. Epub 2018 Jun 14.

PMID:
29903900
33.

Socioeconomic status and risk of kidney dysfunction: the Atherosclerosis Risk in Communities study.

Vart P, Grams ME, Ballew SH, Woodward M, Coresh J, Matsushita K.

Nephrol Dial Transplant. 2018 Jun 11. doi: 10.1093/ndt/gfy142. [Epub ahead of print]

PMID:
29897587
34.

Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Hu JR, Coresh J, Inker LA, Levey AS, Zheng Z, Rebholz CM, Tin A, Appel LJ, Chen J, Sarnak MJ, Grams ME.

Kidney Int. 2018 Aug;94(2):381-389. doi: 10.1016/j.kint.2018.03.008. Epub 2018 Jun 2.

PMID:
29871777
35.

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.

Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, Inker LA, Coresh J, Chang AR, Grams ME.

JAMA Intern Med. 2018 Jul 1;178(7):903-910. doi: 10.1001/jamainternmed.2018.0292.

PMID:
29868840
36.

Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study.

Warren B, Rebholz CM, Sang Y, Lee AK, Coresh J, Selvin E, Grams ME.

Diabetes Care. 2018 Aug;41(8):1646-1653. doi: 10.2337/dc18-0277. Epub 2018 Jun 1.

PMID:
29858211
37.

Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study.

Loomis SJ, Li M, Maruthur NM, Baldridge AS, North KE, Mei H, Morrison A, Carson AP, Pankow JS, Boerwinkle E, Scharpf R, Rasmussen-Torvik LJ, Coresh J, Duggal P, Köttgen A, Selvin E.

Diabetes. 2018 Aug;67(8):1684-1696. doi: 10.2337/db17-1362. Epub 2018 May 29.

38.

Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Tin A, Nadkarni G, Evans AM, Winkler CA, Bottinger E, Rebholz CM, Sarnak MJ, Inker LA, Levey AS, Lipkowitz MS, Appel LJ, Arking DE, Coresh J, Grams ME.

J Am Soc Nephrol. 2018 Jul;29(7):1939-1947. doi: 10.1681/ASN.2017101064. Epub 2018 May 18.

PMID:
29777021
39.

Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study.

Knopman DS, Gottesman RF, Sharrett AR, Tapia AL, DavisThomas S, Windham BG, Coker L, Schneider ALC, Alonso A, Coresh J, Albert MS, Mosley TH Jr.

Alzheimers Dement. 2018 Nov;14(11):1406-1415. doi: 10.1016/j.jalz.2018.03.011. Epub 2018 May 12.

PMID:
29763593
40.

Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K.

Atherosclerosis. 2018 Jul;274:86-93. doi: 10.1016/j.atherosclerosis.2018.04.042. Epub 2018 Apr 30.

PMID:
29753232
41.

A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure.

Nilsson E, De Deco P, Trevisan M, Bellocco R, Lindholm B, Lund LH, Coresh J, Carrero JJ.

Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):267-273. doi: 10.1093/ehjqcco/qcy019.

PMID:
29726982
42.

Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study.

Coresh J, Inker LA, Sang Y, Chen J, Shafi T, Post WS, Shlipak MG, Ford L, Goodman K, Perichon R, Greene T, Levey AS.

Nephrol Dial Transplant. 2018 Apr 30. doi: 10.1093/ndt/gfy094. [Epub ahead of print]

PMID:
29718360
43.

Association of Peripheral Artery Disease With Incident Atrial Fibrillation: The ARIC (Atherosclerosis Risk in Communities) Study.

Bekwelem W, Norby FL, Agarwal SK, Matsushita K, Coresh J, Alonso A, Chen LY.

J Am Heart Assoc. 2018 Apr 17;7(8). pii: e007452. doi: 10.1161/JAHA.117.007452.

44.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

45.

Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study.

McDoom MM, Palta P, Vart P, Juraschek SP, Kucharska-Newton A, Diez Roux AV, Coresh J.

J Hypertens. 2018 Jun;36(6):1382-1390. doi: 10.1097/HJH.0000000000001696.

PMID:
29621068
46.

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J.

Kidney Int. 2018 Jun;93(6):1442-1451. doi: 10.1016/j.kint.2018.01.009. Epub 2018 Mar 29. Erratum in: Kidney Int. 2018 Nov;94(5):1025-1026.

PMID:
29605094
47.

High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Kwak L, Yang C, Pang Y, Ballew SH, Sang Y, Hoogeveen RC, Jaar BG, Selvin E, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Coresh J, Hirsch AT.

Eur Heart J. 2018 Jul 1;39(25):2412-2419. doi: 10.1093/eurheartj/ehy106.

PMID:
29579246
48.

Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.

Hu EA, Selvin E, Grams ME, Steffen LM, Coresh J, Rebholz CM.

Am J Kidney Dis. 2018 Aug;72(2):214-222. doi: 10.1053/j.ajkd.2018.01.030. Epub 2018 Mar 20.

PMID:
29571833
49.

Serum metabolomic profile of incident diabetes.

Rebholz CM, Yu B, Zheng Z, Chang P, Tin A, Köttgen A, Wagenknecht LE, Coresh J, Boerwinkle E, Selvin E.

Diabetologia. 2018 May;61(5):1046-1054. doi: 10.1007/s00125-018-4573-7. Epub 2018 Mar 20.

PMID:
29556673
50.

Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME; CKD Prognosis Consortium .

Eur Heart J. 2018 May 1;39(17):1535-1542. doi: 10.1093/eurheartj/ehy100.

PMID:
29554312

Supplemental Content

Loading ...
Support Center